| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5842035 | Life Sciences | 2014 | 5 Pages | 
Abstract
												These results suggest that GLP-1(9-36) binds and has functional activity in the vasculature but these actions may be via a pathway that is distinct from the classical GLP-1 receptor and insulin secretagogue actions.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Rhoda E. Kuc, Janet J. Maguire, Keith Siew, Sheena Patel, David R. Derksen, V. Margaret Jackson, Kevin M. O'Shaughnessey, Anthony P. Davenport, 
											![First Page Preview: Characterization of [125I]GLP-1(9-36), a novel radiolabeled analog of the major metabolite of glucagon-like peptide 1 to a receptor distinct from GLP1-R and function of the peptide in murine aorta Characterization of [125I]GLP-1(9-36), a novel radiolabeled analog of the major metabolite of glucagon-like peptide 1 to a receptor distinct from GLP1-R and function of the peptide in murine aorta](/preview/png/5842035.png)